Richard Steven Morris

Chief Accounting Officer, ViroPharma.

Companies

Carisma Therapeutics Inc.Chief financial officer Mar 9, 2023 to now¹
Passage BIO, Inc.Chief financial officer Feb 27, 2020 to May 21, 2021²
ViroPharmaChief Accounting Officer Apr 18, 2008 to Jun 6, 2012³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCarisma Therapeutics Inc., Chief financial officer
2
SEC EDGARPassage BIO, Inc., Chief financial officer
3
SEC EDGARViroPharma, Chief Accounting Officer